Hematologic Oncology
ecancer
Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients Undergoing MMUD HCT
FEATURING
Monzr Al Malki,
Steven Devine
- 25 views
- July 24, 2024
ecancer
ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Multiple Myeloma"
FEATURING
Xavier Leleu
- 58 views
- July 18, 2024
- 1
Insights from 2024 EHA Annual Meeting
AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024
FEATURING
Talha Badar
- 580 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Benefit of R Maintenance After 1L BR in MCL"
FEATURING
Yucai Wang
- 47 views
- July 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CAPTIVATE Study - 5.5-Year Follow-Up Outcomes of Fixed-Duration Ibrutinib + Venetoclax in High-risk CLL/SLL"
FEATURING
Ryan Jacobs
- 153 views
- July 8, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Liso-Cel in R/R MCL With Prior BTKi Therapy - Results From TRANSCEND NHL 001"
FEATURING
Leo Gordon
- 43 views
- June 30, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
FEATURING
Bruce D. Cheson
- 1,084 views
- June 19, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"
FEATURING
Patrick Johnson
- 408 views
- June 7, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"
FEATURING
Ola Landgren
- 395 views
- June 12, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and EHA
FEATURING
Kerry Rogers,
Jennifer Woyach
- 247 views
- June 21, 2024
- 1
Insights from 2024 EHA Annual Meeting
Highlights in Plasma Cell Disorders From ASCO® and EHA
FEATURING
Samer Al Hadidi
- 444 views
- June 27, 2024
- 7
ecancer
ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"
FEATURING
Xavier Leleu
- 166 views
- June 24, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation"
FEATURING
Monzr Al Malki
- 259 views
- June 7, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"
FEATURING
Monique Minnema
- 260 views
- June 7, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavily Pretreated R/R MCL"
FEATURING
Tycel Phillips
- 51 views
- June 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "DREAMM-7 Trial - BelamafVd vs. DaraVd in R/R MM"
FEATURING
Maria-Victoria Mateos
- 275 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"
FEATURING
Samir Parekh
- 209 views
- June 25, 2024
- 2
ecancer
ASCO® 2024 Insights: "MajesTEC-7 Study - Safety and Efficacy of Tec-DR in NDMM"
FEATURING
Salomon Manier
- 59 views
- June 26, 2024
ecancer
ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"
FEATURING
Natalia Neparidze
- 62 views
- June 25, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing Liso-Cel vs. SoC With Salvage Chemo and ASCT as 2L Treatment in R/R LBCL"
FEATURING
Manali Kamdar
- 50 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "A Prospective Trial of Combining FDG-PET + Whole-Body MRI for Staging Newly Diagnosed and R/R Myeloma"
FEATURING
Claudio Cerchione
- 203 views
- June 7, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patients With AML - Intensive vs. Non-Intensive Approaches"
FEATURING
Christine McMahon
- 271 views
- June 20, 2024
- 1
ecancer
ASCO® 2024 Insights: "Long-Term Follow-Up of MajesTEC-1 Trial - Teclistamab in R/R MM"
FEATURING
Alfred Garfall
- 13 views
- June 20, 2024
ecancer
ASCO® 2024 Insights: "CARTITUDE-4 Study - Benefits of Ciltacabtagene Autoleucel in Lenalidomide-Refractory Functional High-Risk MM"
FEATURING
Luciano Costa
- 93 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Real World Outcomes of Pts With MM Who Received Bispecific Antibodies After CAR-T"
FEATURING
Radhika Bansal
- 116 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Indirect Comparison of Linvoseltamab Vs. Teclistamab for Triple-Class Exposed R/R MM"
FEATURING
Sundar Jagannath
- 170 views
- June 17, 2024
- 2
ecancer
ASCO® 2024 Insights: "PERSEUS Trial - MRD Analysis of Dara + VRd in Transplant-Eligible NDMM"
FEATURING
Paula Rodríguez-Otero
- 55 views
- June 24, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Status of Bispecific Antibody Therapy in R/R MM"
FEATURING
Meera Mohan
- 130 views
- June 16, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Understanding New Strategies to Prevent and Manage Chronic GVHD"
FEATURING
Betty Hamilton
- 47 views
- June 16, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MRD2STOP Study - Discontinuation of Maintenance Therapy in MM Guided by Multimodal MRD Negativity"
FEATURING
Ben Derman
- 365 views
- June 11, 2024
- 2
ecancer
ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd vs. VRd for Transplant-Ineligible NDMM"
FEATURING
Thierry Facon
- 89 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults With Myeloid Malignancies"
FEATURING
Kah Poh Loh
- 88 views
- June 16, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"
FEATURING
Cathy Burton
- 91 views
- June 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "New Agents on the Horizon in NHL and Myeloma - Targets Other Than CD3/CD20, New Constructs, and Trispecifics"
FEATURING
Paolo Strati
- 37 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The BENEFIT Study - Isa-VRd vs. Isa-Rd for Transplant-Ineligible NDMM"
FEATURING
Xavier Leleu
- 142 views
- June 11, 2024